Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Mark A Goldsmith. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Mark A Goldsmith har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:RVMD / Revolution Medicines, Inc. | See Remarks, Director | 465 720 |
Director | 0 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Mark A Goldsmith. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp RVMD / Revolution Medicines, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i RVMD / Revolution Medicines, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel RVMD / Revolution Medicines, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i RVMD / Revolution Medicines, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Mark A Goldsmith som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-07-02 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 37 000 | 465 720 | 8,63 | 0,54 | 19 980 | 251 489 | |
2025-06-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −13 496 | 428 720 | −3,05 | 39,83 | −537 546 | 17 075 918 |
2025-03-19 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −11 738 | 441 564 | −2,59 | 39,04 | −458 255 | 17 238 791 |
2025-03-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
A - Award | 97 400 | 453 302 | 27,37 | ||||
2024-12-20 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 30 846 | 355 902 | 9,49 | 0,49 | 15 115 | 174 392 | |
2024-12-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −11 714 | 325 056 | −3,48 | 45,40 | −531 860 | 14 758 778 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 36 600 | 336 770 | 12,19 | 0,49 | 17 934 | 165 017 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −50 900 | 300 170 | −14,50 | 55,56 | −2 827 821 | 16 676 365 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 50 900 | 351 070 | 16,96 | 4,09 | 208 181 | 1 435 876 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 20 424 | −19,67 | 55,02 | −275 104 | 1 123 747 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 20 424 | −19,67 | 55,03 | −275 134 | 1 123 867 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −9 100 | 300 170 | −2,94 | 55,02 | −500 714 | 16 516 404 |
2024-11-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 9 100 | 309 270 | 3,03 | 4,09 | 37 219 | 1 264 914 |
2024-10-15 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −30 000 | 300 170 | −9,09 | 50,36 | −1 510 773 | 15 116 291 |
2024-10-15 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 30 000 | 330 170 | 9,99 | 4,09 | 122 700 | 1 350 395 |
2024-10-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −2 022 | 300 170 | −0,67 | 45,46 | −91 913 | 13 644 708 |
2024-10-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −7 978 | 302 192 | −2,57 | 44,80 | −357 409 | 13 537 990 |
2024-10-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 10 000 | 310 170 | 3,33 | 4,09 | 40 900 | 1 268 595 |
2024-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −11 715 | 300 170 | −3,76 | 44,19 | −517 631 | 13 263 102 |
2024-08-02 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −3 217 | 311 885 | −1,02 | 46,48 | −149 519 | 14 495 760 |
2024-08-02 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −6 783 | 315 102 | −2,11 | 45,60 | −309 308 | 14 368 777 |
2024-08-02 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 10 000 | 321 885 | 3,21 | 4,09 | 40 900 | 1 316 510 |
2024-07-16 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 25 424 | −16,43 | 45,01 | −225 059 | 1 144 380 |
2024-07-16 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 25 424 | −16,43 | 45,01 | −225 058 | 1 144 375 |
2024-07-16 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −25 000 | 311 885 | −7,42 | 45,05 | −1 126 205 | 14 049 858 |
2024-07-16 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 25 000 | 336 885 | 8,02 | 4,09 | 102 250 | 1 377 860 |
2024-06-20 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −11 950 | 311 885 | −3,69 | 37,39 | −446 770 | 11 660 320 |
2024-06-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −901 | 322 322 | −0,28 | 40,93 | −36 881 | 13 193 703 |
2024-06-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 699 | 323 223 | −1,73 | 39,99 | −227 880 | 12 924 363 |
2024-06-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −900 | 328 922 | −0,27 | 39,09 | −35 182 | 12 857 857 |
2024-06-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 7 500 | 329 822 | 2,33 | 4,09 | 30 675 | 1 348 972 |
2024-04-12 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 30 424 | −14,11 | 35,34 | −176 687 | 1 075 105 |
2024-04-12 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 30 424 | −14,11 | 35,33 | −176 658 | 1 074 932 |
2024-04-12 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −7 500 | 452 879 | −1,63 | 35,48 | −266 122 | 16 069 460 |
2024-03-20 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 788 | 460 379 | −1,24 | 31,58 | −182 804 | 14 540 242 |
2024-03-05 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
A - Award | −90 000 | 466 167 | −16,18 | ||||
2023-12-20 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −8 165 | 376 167 | −2,12 | 25,90 | −211 488 | 9 743 402 |
2023-10-24 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 35 000 | 384 332 | 10,02 | 0,49 | 17 150 | 188 323 | |
2023-09-20 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | −8 054 | 349 332 | −2,25 | 31,31 | −252 175 | 10 937 760 | |
2023-09-06 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 35 424 | −12,37 | 35,04 | −175 219 | 1 241 392 |
2023-09-06 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 35 424 | −12,37 | 35,04 | −175 191 | 1 241 193 |
2023-09-06 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −30 000 | 357 386 | −7,74 | 35,05 | −1 051 563 | 12 527 130 |
2023-09-06 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 12 007 | 387 386 | 3,20 | 1,12 | 13 448 | 433 872 |
2023-09-06 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 17 993 | 375 379 | 5,03 | 0,54 | 9 716 | 202 705 |
2023-03-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
A - Award | 104 000 | 355 872 | 41,29 | ||||
2023-02-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 45 000 | 251 872 | 21,75 | 0,49 | 22 050 | 123 417 | |
2022-08-15 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 10 000 | 206 872 | 5,08 | 0,49 | 4 900 | 101 367 | |
2022-08-10 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 10 336 | 196 872 | 5,54 | 0,49 | 5 065 | 96 467 | |
2022-03-21 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | −1 023 | 185 599 | −0,55 | 18,61 | −19 042 | 3 454 758 | |
2022-03-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
A - Award | 363 000 | 363 000 | |||||
2022-03-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
A - Award | 104 000 | 186 622 | 125,87 | ||||
2021-12-21 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | −1 571 | 82 622 | −1,87 | 24,41 | −38 348 | 2 016 803 | |
2021-12-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | −37 721 | 167 782 | −18,36 | ||||
2021-12-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | 37 721 | 84 193 | 81,17 | 0,49 | 18 483 | 41 255 | |
2021-09-21 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | −1 531 | 46 472 | −3,19 | 30,02 | −45 961 | 1 395 089 | |
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Options (Right to buy) |
D - Sale to Issuer | −13 171 | 0 | −100,00 | ||||
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
D - Sale to Issuer | −9 083 | 0 | −100,00 | ||||
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
D - Sale to Issuer | −12 446 | 0 | −100,00 | ||||
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
D - Sale to Issuer | −13 171 | 0 | −100,00 | ||||
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
D - Sale to Issuer | −6 825 | 0 | −100,00 | ||||
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −13 171 | 0 | −100,00 | ||||
2021-07-19 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −89 857 | 0 | −100,00 | ||||
2021-06-22 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | −20 | 48 003 | −0,04 | 33,50 | −670 | 1 607 947 | |
2021-06-22 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | −1 465 | 48 023 | −2,96 | 34,13 | −50 000 | 1 639 025 | |
2021-06-04 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 13 171 | 13 171 | |||||
2021-03-08 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −14 987 | 0 | −100,00 | ||||
2021-03-08 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 987 | 14 987 | |||||
2021-03-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
A - Award | 169 000 | 169 000 | |||||
2021-03-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
A - Award | 48 000 | 48 744 | 6 451,61 | ||||
2021-03-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 58 486 | −7,88 | |||
2021-03-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 000 | 744 | −87,05 | 46,00 | −229 981 | 34 221 |
2021-03-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 744 | 672,04 | 1,12 | 5 600 | 6 433 |
2021-02-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −15 000 | 63 486 | −19,11 | |||
2021-02-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −15 000 | 744 | −95,27 | 55,00 | −825 000 | 40 920 |
2021-02-08 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 15 000 | 15 744 | 2 016,13 | 1,12 | 16 800 | 17 633 |
2021-02-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 78 486 | −5,99 | |||
2021-02-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −800 | 744 | −51,81 | 46,26 | −37 005 | 34 415 |
2021-02-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −4 200 | 1 544 | −73,12 | 45,26 | −190 096 | 69 883 |
2021-02-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 5 000 | 5 744 | 672,04 | 1,12 | 5 600 | 6 433 |
2021-02-03 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
G - Gift | −246 604 | 247 093 | −49,95 | ||||
2020-12-28 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 020 | 139 043 | −2,81 | 35,02 | −140 769 | 4 868 897 |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −30 | 83 486 | −0,04 | |||
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −42 548 | 520 841 | −7,55 | |||
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −1 312 | 71 879 | −1,79 | 34,12 | −44 762 | 2 452 339 |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −42 578 | 0 | −100,00 | 34,40 | −1 464 854 | |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 30 | 42 578 | 0,07 | 1,12 | 34 | 47 687 |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 42 548 | 42 548 | 4,73 | 201 252 | 201 252 | |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −20 076 | 563 389 | −3,44 | |||
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 447 | 331 229 | −3,06 | |||
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −21 088 | 73 191 | −22,37 | 34,08 | −718 652 | 2 494 254 |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −30 523 | 0 | −100,00 | 34,14 | −1 041 918 | |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 20 076 | 30 523 | 192,17 | 4,73 | 94 959 | 144 374 |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 10 447 | 10 447 | 4,09 | 42 728 | 42 728 | |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 132 | 341 676 | −2,88 | |||
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −7 500 | 94 279 | −7,37 | 34,08 | −255 605 | 3 213 094 |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −10 132 | 0 | −100,00 | 34,11 | −345 567 | |
2020-09-30 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 10 132 | 10 132 | 4,09 | 41 440 | 41 440 | |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −100 | 351 808 | −0,03 | |||
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −100 | 101 779 | −0,10 | 34,02 | −3 402 | 3 462 522 |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 34,01 | −3 401 | |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 100 | 100 | 4,09 | 409 | 409 | |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −10 097 | 351 908 | −2,79 | |||
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −541 | 101 879 | −0,53 | 33,00 | −17 853 | 3 362 007 |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −10 097 | 0 | −100,00 | 33,15 | −334 713 | |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 10 097 | 10 097 | 4,09 | 41 297 | 41 297 | |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −29 903 | 362 005 | −7,63 | |||
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −11 459 | 102 420 | −10,06 | 33,00 | −378 173 | 3 380 096 |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −29 903 | 0 | −100,00 | 33,00 | −986 850 | |
2020-09-23 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 29 903 | 29 903 | 4,09 | 122 303 | 122 303 | |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −6 056 | 391 908 | −1,52 | |||
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 286 | 83 516 | −1,52 | |||
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −712 | 113 879 | −0,62 | 31,05 | −22 106 | 3 535 613 |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −200 | 0 | −100,00 | 32,18 | −6 437 | |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −7 142 | 200 | −97,28 | 31,66 | −226 084 | 6 331 |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 6 056 | 7 342 | 470,92 | 4,09 | 24 769 | 30 029 |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 1 286 | 1 286 | 1,12 | 1 440 | 1 440 | |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −27 363 | 84 802 | −24,40 | |||
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −11 288 | 114 591 | −8,97 | 31,03 | −350 311 | 3 556 206 |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −22 658 | 0 | −100,00 | 31,04 | −703 191 | |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −4 705 | 22 658 | −17,19 | 29,76 | −140 030 | 674 347 |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 27 363 | 27 363 | 1,12 | 30 647 | 30 647 | |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −8 813 | 112 165 | −7,28 | |||
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −8 813 | 0 | −100,00 | 29,04 | −255 956 | |
2020-09-18 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 8 813 | 8 813 | 1,12 | 9 871 | 9 871 | |
2020-09-11 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −2 544 | 120 978 | −2,06 | |||
2020-09-11 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −4 399 | 125 879 | −3,38 | 29,00 | −127 571 | 3 650 491 |
2020-09-11 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −2 544 | 0 | −100,00 | 29,07 | −73 948 | |
2020-09-11 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 2 544 | 2 544 | 1,12 | 2 849 | 2 849 | |
2020-09-11 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −100 | 130 251 | −0,08 | 29,00 | −2 900 | 3 777 279 |
2020-09-10 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −900 | 123 522 | −0,72 | |||
2020-09-10 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −900 | 130 351 | −0,69 | 29,05 | −26 141 | 3 786 097 |
2020-09-10 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −900 | 0 | −100,00 | 29,05 | −26 145 | |
2020-09-10 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 900 | 900 | 1,12 | 1 008 | 1 008 | |
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −500 | 124 422 | −0,40 | |||
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −700 | 131 251 | −0,53 | 29,07 | −20 352 | 3 816 031 |
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 29,07 | −14 533 | |
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 500 | 500 | 1,12 | 560 | 560 | |
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 100 | 124 922 | −0,87 | |||
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −800 | 131 951 | −0,60 | 29,02 | −23 213 | 3 828 717 |
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −1 100 | 0 | −100,00 | 29,05 | −31 960 | |
2020-09-04 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 1 100 | 1 100 | 1,12 | 1 232 | 1 232 | |
2020-08-31 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −1 438 | 126 022 | −1,13 | |||
2020-08-31 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −1 101 | 132 751 | −0,82 | 29,01 | −31 939 | 3 850 987 |
2020-08-31 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −1 438 | 0 | −100,00 | 29,01 | −41 713 | |
2020-08-31 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 1 438 | 1 438 | 1,12 | 1 611 | 1 611 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −9 700 | 127 460 | −7,07 | |||
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −3 900 | 133 852 | −2,83 | 27,57 | −107 522 | 3 690 259 |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 232 | 0 | −100,00 | 28,28 | −147 978 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 5 232 | 5 232 | 1,12 | 5 860 | 5 860 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −4 468 | 0 | −100,00 | 27,49 | −122 809 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 4 468 | 4 468 | 1,12 | 5 004 | 5 004 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
M - Exercise | X | −16 967 | 137 160 | −11,01 | |||
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −100 | 137 752 | −0,07 | 27,51 | −2 751 | 3 789 558 |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −600 | 137 852 | −0,43 | 26,76 | −16 054 | 3 688 465 |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −5 400 | 138 452 | −3,75 | 25,79 | −139 249 | 3 570 234 |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −400 | 0 | −100,00 | 27,72 | −11 090 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 400 | 400 | 1,12 | 448 | 448 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −1 983 | 0 | −100,00 | 26,63 | −52 811 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 1 983 | 1 983 | 1,12 | 2 221 | 2 221 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
S - Sale | X | −14 584 | 0 | −100,00 | 25,77 | −375 859 | |
2020-08-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Common Stock |
M - Exercise | X | 14 584 | 14 584 | 1,12 | 16 334 | 16 334 | |
2020-06-08 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Options (Right to buy) |
A - Award | 13 171 | 13 171 | |||||
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −1 300 | 12 446 | −9,46 | ||||
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −300 | 6 825 | −4,21 | ||||
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −2 625 | 14 987 | −14,90 | ||||
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 225 | 143 063 | −2,87 | 50,05 | −211 474 | 7 160 747 |
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 300 | 147 288 | 0,89 | 7,60 | 9 880 | 1 119 389 | |
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 300 | 145 988 | 0,21 | 11,50 | 3 450 | 1 678 862 | |
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 625 | 145 688 | 1,83 | 1,55 | 4 069 | 225 816 | |
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −100 | 17 612 | −0,56 | ||||
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 143 063 | −0,07 | 50,00 | −5 000 | 7 153 150 |
2020-05-13 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 100 | 143 163 | 0,07 | 1,55 | 155 | 221 903 | |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −3 900 | 13 746 | −22,10 | ||||
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −750 | 7 125 | −9,52 | ||||
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −6 813 | 17 712 | −27,78 | ||||
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 463 | 143 063 | −7,42 | 45,06 | −516 545 | 6 446 691 |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 900 | 154 526 | 2,59 | 7,60 | 29 640 | 1 174 398 | |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 750 | 150 626 | 0,50 | 11,50 | 8 625 | 1 732 199 | |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 813 | 149 876 | 4,76 | 1,55 | 10 560 | 232 308 | |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −520 | 17 646 | −2,86 | ||||
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −300 | 7 875 | −3,67 | ||||
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −2 325 | 24 525 | −8,66 | ||||
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 145 | 143 063 | −2,15 | 40,01 | −125 824 | 5 723 607 |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 520 | 146 208 | 0,36 | 7,60 | 3 952 | 1 111 181 | |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 300 | 145 688 | 0,21 | 11,50 | 3 450 | 1 675 412 | |
2020-05-07 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 325 | 145 388 | 1,63 | 1,55 | 3 604 | 225 351 | |
2020-04-29 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −400 | 26 850 | −1,47 | ||||
2020-04-29 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 143 063 | −0,28 | 40,12 | −16 049 | 5 740 045 |
2020-04-29 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
M - Exercise | 400 | 143 463 | 0,28 | 1,55 | 620 | 222 368 | |
2020-02-14 |
|
4 | RVMD |
Revolution Medicines, Inc.
Stock Option (Right to Buy) |
A - Award | 128 439 | 128 439 | |||||
2020-02-12 | 3 | RVMD |
Revolution Medicines, Inc.
Common Stock |
1 130 268 | ||||||||
2020-02-12 | 3 | RVMD |
Revolution Medicines, Inc.
Common Stock |
780 912 | ||||||||
2020-02-12 | 3 | RVMD |
Revolution Medicines, Inc.
Common Stock |
1 130 268 | ||||||||
2020-02-12 | 3 | RVMD |
Revolution Medicines, Inc.
Common Stock |
780 912 | ||||||||
2020-02-12 | 3 | RVMD |
Revolution Medicines, Inc.
Common Stock |
1 130 268 | ||||||||
2020-02-12 | 3 | RVMD |
Revolution Medicines, Inc.
Common Stock |
780 912 | ||||||||
2019-06-10 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 13 171 | 13 171 | |||||
2018-07-20 |
|
4 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 8 175 | 8 175 | |||||
2018-07-18 | 3 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
273 410 | ||||||||
2018-07-18 | 3 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
155 779 | ||||||||
2018-07-18 | 3 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
273 410 | ||||||||
2018-07-18 | 3 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
155 779 | ||||||||
2018-07-18 | 3 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
273 410 | ||||||||
2018-07-18 | 3 | CNST |
CONSTELLATION PHARMACEUTICALS INC
Common Stock |
155 779 |